Moya A, Sutton R, Ammirati F, et al; the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009 Nov;30(21):2631-71.
Greenland P, Alpert JS, Beller GA, et al; American College of Cardiology Foundation, American Heart Association. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. J Am Coll Cardiol. 2010;56:e50-e103.
1. Josephson ME. Clinical cardiac electrophysiology: techniques and interpretations. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
2. Cheng S, Keyes MJ, Larson MG, et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA. 2009;301:2571-2577.
3. Upshaw CB Jr. Comparison of the prevalence of first-degree atrioventricular block in African-American and in Caucasian patients: an electrocardiographic study III. J Natl Med Assoc. 2004 Jun;96(6):756-60.
4. DePaula RS, Antelmi I, Vincenzi MA, et al. Cardiac arrhythmias and atrioventricular block in a cohort of asymptomatic individuals without heart disease. Cardiology. 2007;108(2):111-6.
5. Kwok CS, Rashid M, Beynon R, et al. Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis. Heart. 2016 May;102(9):672-80.
6. Kreger BE, Anderson KM, Kannel WB. Prevalence of intraventricular block in the general population: the Framingham Study. Am Heart J. 1989 Apr;117(4):903-10.
7. Moya A, Sutton R, Ammirati F, et al; the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009 Nov;30(21):2631-71.
8. Deisenhofer I, Zrenner B, Yin YH, et al. Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO Study): results from a large multicenter prospective randomized trial. Circulation. 2010 Nov 30;122(22):2239-45.
9. Royer A, van Veen TA, Le Bouter S, et al. Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis. Circulation. 2005 Apr 12;111(14):1738-46.
10. Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Heart Rhythm. 2012 Oct;9(10):1737-53.
11. Lenegre J. Etiology and pathology of bilateral bundle branch block in relation to complete heart block. Prog Cardiovasc Dis. 1964 Mar;6:409-44.
12. Lev M. Anatomic basis for atrioventricular block. Am J Med. 1964 Nov;37:742-8.
13. Zoob M, Smith KS. The aetiology of complete heart-block. Br Med J. 1963 Nov 9;2(5366):1149-53.
14. European Society of Cardiology (ESC) Task Force on cardiac pacing and resynchronization therapy; European Heart Rhythm Association (EHRA). 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2013 Aug;34(29):2281-329.
15. Simon AB, Steinke WE, Curry JJ. Atrioventricular block in acute myocardial infarction. Chest. 1972 Aug;62(2):156-61.
16. Ruiz-Bailén M, Pola Gallego MD, Expósito Ruiz M, et al. Atrioventricular block in unstable angina: results of the ARIAM registry [in Spanish]. Med Intensiva. 2006 Dec;30(9):432-9.
17. Hreybe H, Saba S. Location of acute myocardial infarction and associated arrhythmias and outcome. Clin Cardiol. 2009 May;32(5):274-7.
18. Amsterdam EA, Wenger NK, Brindis RG, et al; ACC/AHA Task Force Members. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 23;130(25):e344-426.
19. Chapelon-Abric C, de Zuttere D, Duhaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore). 2004 Nov;83(6):315-34.
20. Puech P, Grolleau R, Buimond C. Incidence of different types of A-V block and their localization by His bundle recordings. In: Wellens HJ, Lie KI, Janse MJ, eds. The conduction system of the heart: structure, function, and clinical implications. Philadelphia, PA: Lea & Febiger; 1976:467-484.
21. McAlister HF, Klementowicz PT, Andrews C, et al. Lyme carditis: an important cause of reversible heart block. Ann Intern Med. 1989 Mar 1;110(5):339-45.
22. Fenton AM, Hammill SC, Rea RF, et al. Vasovagal syncope. Ann Intern Med. 2000;133:714-725.
23. Kindermann M, Hennen B, Jung J, et al. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol. 2006:47:1927-1937.
24. Funck RC, Blanc JJ, Mueller HH, et al; BioPace Study Group. Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the 'Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)' study. Europace. 2006;8:629-635.
25. Dickstein K, Vardas PE, Auricchio A, et al. 2010 focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J. 2010;31:2677-2687.
26. Sumiyoshi M, Nakata Y, Yasuda M, et al. Changes of conductivity in patients with second- or third-degree atrioventricular block after pacemaker implantation. Jpn Circ J. 1995;59:284-291.
27. Curtis AB, Worley SJ, Adamson PB, et al; Biventricular Versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block (BLOCK HF) Trial Investigators. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med. 2013;368:1585-1593.
28. Victor F, Mabo P, Mansour H, et al. A randomized comparison of permanent septal versus apical right ventricular pacing: short term results. J Cardiovasc Electrophysiol. 2006;17:238-242.
29. Victor F, Leclercq C, Mabo P, et al. Optimal right ventricular pacing site in chronically implanted patients: a prospective randomized crossover comparison of apical and outflow tract pacing. J Am Coll Cardiol. 1999;33:311-316.
30. Tse HF, Yu C, Wong KK, et al. Functional abnormalities in patients with permanent right ventricular pacing:the effect of sites of electrical stimulation. J Am Coll Cardiol. 2002;40:1451-1458.
31. Occhetta E, Bortnik M, Magnani A, et al. Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing. J Am Coll Cardiol. 2006;47:1938-1945.
32. Kaye GC, Linker NJ, Marwick TH, et al; Protect-Pace trial investigators. Effect of right ventricular pacing lead site on left ventricular function in patients with high-grade atrioventricular block: results of the Protect-Pace study. Eur Heart J. 2015;36:856-862.
33. Plotnikov AN, Shlapakova I, Szabolcs MJ, et al. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation. 2007;116:706-713.
34. Goto H, Sugiura T, Harada Y, et al. Feasibility of using the automatic generating system for quartz watches as a leadless pacemaker power source. Med Biol Eng Comput. 1999;37:377-380.
35. Lee KL, Tse HF, Echt DS, et al. Temporary leadless pacing in heart failure patients with ultrasound-mediated stimulation energy and effects on the acoustic window. Heart Rhythm. 2009;6:742-748.
36. Lee KL, Lau CP, Tse HF, et al. First human demonstration of cardiac stimulation with transcutaneous ultrasound energy delivery: implications for wireless pacing with implantable devices. J Am Coll Cardiol. 2007;50:877-883.
37. Echt DS, Cowan MW, Riley RE, et al. Feasibility and safety of a novel technology for pacing without leads. Heart Rhythm. 2006;3:1202-1206.
38. Reddy VY, Exner DV, Cantillon DJ, et al.; LEADLESS II Study Investigators. Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med. 2015;373:1125-1135.
39. Greenland P, Alpert JS, Beller GA, et al; American College of Cardiology Foundation, American Heart Association. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. J Am Coll Cardiol. 2010;56:e50-e103.
40. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest. 2005;128:30-35.
41. Skinner M, Anderson J, Simms R, et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med. 1996;100:290-298.
42. Santangeli P, Ferrante G, Pelargonio G, et al. Usefulness of statins in preventing atrial fibrillation in patients with permanent pacemaker: a systematic review. Europace. 2010;12:649-654.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台